Paxlovid Is First COVID-19 Rx Product To Get AdComm On Move From EUA To Full Approval
Executive Summary
Approval seems assured, but US FDA advisory committee is forum for sharing evidence for use of Paxlovid in those infected with the Omicron variant and in immunocompromised individuals, as well as discussing the Pfizer product’s possible association with COVID-19 rebound.